Cation-independent mannose 6-phosphate receptor: From roles and functions to targeted therapies

Archive ouverte

Gauthier, Corentin | El Cheikh, Khaled | Basile, Ilaria | Daurat, Morgane | Morère, Elodie | Garcia, Marcel | Maynadier, Marie | Morère, Alain | Gary-Bobo, Magali

Edité par CCSD ; Elsevier -

International audience. The cation-independent mannose 6-phosphate receptor (CI-M6PR) is a ubiquitous transmembrane receptor whose main intracellular role is to direct enzymes carrying mannose 6-phosphate moieties to lysosomal compartments. Recently, the small membrane-bound portion of this receptor has appeared to be implicated in numerous pathophysiological processes. This review presents an overview of the main ligand partners and the roles of CI-M6PR in lysosomal storage diseases, neurology, immunology and cancer fields. Moreover, this membrane receptor has already been noted for its strong potential in therapeutic applications thanks to its cellular internalization activity and its ability to address pathogenic factors to lysosomes for degradation. A number of therapeutic delivery approaches using CI-M6PR, in particular with enzymes, antibodies or nanoparticles, are currently being proposed.

Consulter en ligne

Suggestions

Du même auteur

Engineered therapeutic antibodies with mannose 6-phosphate analogues as a tool to degrade extracellular proteins

Archive ouverte | Daurat, Morgane | CCSD

International audience. Inducing the degradation of pathological soluble antigens could be the key to greatly enhancing the efficacy of therapeutic monoclonal antibodies (mAbs), extensively used in the treatment of ...

Therapeutic antibody engineering for efficient targeted degradation of membrane proteins in lysosomes

Archive ouverte | Gauthier, Corentin | CCSD

International audience. Targeted degradation of pathological proteins is a promising approach to enhance the effectiveness of therapeutic monoclonal antibodies (mAbs) in cancer therapy. In this study, we demonstrate...

Efficient therapy for refractory Pompe disease by mannose 6-phosphate analogue grafting on acid α-glucosidase

Archive ouverte | Basile, Ilaria | CCSD

Pompe disease is a rare disorder due to deficiency of the acid a-glucosidase (GAA) treated by enzyme replacement therapy. The present authorized treatment with rhGAA, the recombinant human enzyme, provides an important benefit in ...

Chargement des enrichissements...